Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
Trading-Depot
>
19.03.2025 16:15:12

EQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

EQS-News: STRATEC SE / Key word(s): Miscellaneous
STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

19.03.2025 / 16:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

Birkenfeld, March 19, 2025

STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) is today announcing a postponement in the publication date for its 2024 Annual Report. Publication is now scheduled for April 29, 2025. This postponement is to be viewed in connection with the increased time and coordination required due to the change of external auditor (initial audit), as well as with capacity bottlenecks, some of which sickness-related, in the finance department.

Prior to publication of its Annual Report, STRATEC plans to publish its preliminary results for the 2024 financial year together with its guidance for 2025. The exact date for this publication will be announced in advance. Based on current information, STRATEC expects that the targets formulated for the 2024 financial year, namely consolidated sales to remain stable or decline slightly (on a constant-currency basis) and an adjusted EBIT margin of around 10.0% to 12.0%, have been met.

Given mandatory convocation deadlines, the new publication date for the 2024 Annual Report will also make it necessary to postpone the Annual General Meeting scheduled to take place on May 23, 2025. The 2025 Annual General Meeting will now be held on June 17, 2025.

ABOUT STRATEC
STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler, CFA | Investor Relations, Sustainability & Corporate Communications
Tel: +49 7082 7916-6515
ir@stratec.com
www.stratec.com



19.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: STRATEC SE
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec.com
Internet: www.stratec.com
ISIN: DE000STRA555
WKN: STRA55
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2103158

 
End of News EQS News Service

2103158  19.03.2025 CET/CEST

Analysen zu STRATEC SE

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
20.01.25 STRATEC Buy Warburg Research
20.01.25 STRATEC Hold Deutsche Bank AG
19.12.24 STRATEC Halten DZ BANK
27.11.24 STRATEC Buy Warburg Research
12.11.24 STRATEC Hold Hauck Aufhäuser Lampe Privatbank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Warren Buffett – Hot Picks – Wall Street Live mit Tim Schäfer

In diesem spannenden Video spricht Tim Schäfer über die Investment-Philosophie von Warren Buffett und warum langfristiges Buy & Hold auch heute noch funktioniert. Gemeinsam werfen wir einen Blick auf Berkshire Hathaway, die Lieblingsaktie von Tim, und analysieren die grössten Positionen des Star-Investors – von Apple über Coca-Cola bis hin zu Occidental Petroleum.

✅ Welche Dividendenaktien lohnen sich wirklich?
✅ Warum Buffett Milliarden in Cash hält
✅ Wie du dein Depot stabil und renditestark aufbaust
✅ Welche Titel Buffett kürzlich reduziert – und wo er verstärkt einsteigt
✅ Tipps von Tim Schäfer aus erster Hand – direkt von der Wall Street!

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Warren Buffett – Hot Picks – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’617.96 19.51 UBSP6U
Short 13’884.49 13.76 3OUBSU
Short 14’404.72 8.92 UJ1BSU
SMI-Kurs: 13’097.05 20.03.2025 17:31:08
Long 12’507.38 19.22 BJJSAU
Long 12’228.83 13.54 B4OSIU
Long 11’740.00 8.88
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

STRATEC SE 34.65 -1.74% STRATEC SE

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}